More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.
Broad approach needed against pharmaceutical residues in environment We can all help to reduce pollution of the environment by pharmaceutical residues.
Icy air measurements Bernice Notenboom’s Arctic March expedition team has reached the summit of Greenland. She has conquered the 3500-metre high summit on Greenland with functioning air measuring equipment.
Vaccination using needles: there are alternatives Dr Hoang Hirschberg, employed at RIVM, has carried out PhD research into three alternatives for needle injections. She concluded that all alternatives have advantages and limitations.
Injection needles: fact-finding and risk assessment of excess adhesive Commissioned by the Dutch Health Care Inspectorate (IGZ), RIVM investigated whether excess adhesive is present in two types of injection needles from the Terumo Company (K-Pack II and Neolus).
Points of special interest in home treatment with complex medical technologies Patients are increasingly being treated with complex medical technologies in their own home. This offers great benefits, however, it also introduces risks.
Climate reporter Bernice Notenboom arrives in Greenland for continuation of climate expedition Climate reporter and expedition leader Bernice Notenboom and her team left for Greenland on 4 May 2015 for the second part of the Arctic March.